The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Grade Injectable Activated Carbon Market Research Report 2025
Synopsis
The global market for Pharmaceutical Grade Injectable Activated Carbon was valued at US$ 101 million in the year 2024 and is projected to reach a revised size of US$ 166 million by 2031, growing at a CAGR of 7.4% during the forecast period.
Pharmaceutical grade activated carbon is a highly porous and adsorptive material that is commonly used in the purification of drugs and pharmaceuticals. It is produced from high-quality raw materials, such as coconut shells or wood, through a process of activation that involves heating them in the presence of a gas, such as steam or carbon dioxide. The resulting activated carbon has a large surface area and a high degree of microporosity, which makes it highly effective at adsorbing impurities from liquids and gases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Injectable Activated Carbon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Injectable Activated Carbon.
The Pharmaceutical Grade Injectable Activated Carbon market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Grade Injectable Activated Carbon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Grade Injectable Activated Carbon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Calgon Carbon
Fujian Yuanli Activated Carbon
Zhejiang Xingda Activated Carbon
Jiangsu Zhuxi Activated Carbon
Shanghai Activated Carbon
by Type
For Injection Type 732
For Injection Type 767
For Injection Type 769
Other
by Application
Small Volume Injection
Large Volume Injection
Powder for Injection
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Grade Injectable Activated Carbon manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical Grade Injectable Activated Carbon by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical Grade Injectable Activated Carbon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global market for Pharmaceutical Grade Injectable Activated Carbon was valued at US$ 101 million in the year 2024 and is projected to reach a revised size of US$ 166 million by 2031, growing at a CAGR of 7.4% during the forecast period.
Pharmaceutical grade activated carbon is a highly porous and adsorptive material that is commonly used in the purification of drugs and pharmaceuticals. It is produced from high-quality raw materials, such as coconut shells or wood, through a process of activation that involves heating them in the presence of a gas, such as steam or carbon dioxide. The resulting activated carbon has a large surface area and a high degree of microporosity, which makes it highly effective at adsorbing impurities from liquids and gases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Injectable Activated Carbon, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Injectable Activated Carbon.
The Pharmaceutical Grade Injectable Activated Carbon market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Grade Injectable Activated Carbon market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Grade Injectable Activated Carbon manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Calgon Carbon
Fujian Yuanli Activated Carbon
Zhejiang Xingda Activated Carbon
Jiangsu Zhuxi Activated Carbon
Shanghai Activated Carbon
by Type
For Injection Type 732
For Injection Type 767
For Injection Type 769
Other
by Application
Small Volume Injection
Large Volume Injection
Powder for Injection
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Grade Injectable Activated Carbon manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Pharmaceutical Grade Injectable Activated Carbon by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Pharmaceutical Grade Injectable Activated Carbon in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Pharmaceutical Grade Injectable Activated Carbon Market Overview
1.1 Product Definition
1.2 Pharmaceutical Grade Injectable Activated Carbon by Type
1.2.1 Global Pharmaceutical Grade Injectable Activated Carbon Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 For Injection Type 732
1.2.3 For Injection Type 767
1.2.4 For Injection Type 769
1.2.5 Other
1.3 Pharmaceutical Grade Injectable Activated Carbon by Application
1.3.1 Global Pharmaceutical Grade Injectable Activated Carbon Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Small Volume Injection
1.3.3 Large Volume Injection
1.3.4 Powder for Injection
1.3.5 Other
1.4 Global Market Growth Prospects
1.4.1 Global Pharmaceutical Grade Injectable Activated Carbon Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Pharmaceutical Grade Injectable Activated Carbon Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Pharmaceutical Grade Injectable Activated Carbon Production Estimates and Forecasts (2020-2031)
1.4.4 Global Pharmaceutical Grade Injectable Activated Carbon Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Pharmaceutical Grade Injectable Activated Carbon Production Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical Grade Injectable Activated Carbon Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Pharmaceutical Grade Injectable Activated Carbon, Industry Ranking, 2023 VS 2024
2.4 Global Pharmaceutical Grade Injectable Activated Carbon Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharmaceutical Grade Injectable Activated Carbon Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Pharmaceutical Grade Injectable Activated Carbon, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Pharmaceutical Grade Injectable Activated Carbon, Product Offered and Application
2.8 Global Key Manufacturers of Pharmaceutical Grade Injectable Activated Carbon, Date of Enter into This Industry
2.9 Pharmaceutical Grade Injectable Activated Carbon Market Competitive Situation and Trends
2.9.1 Pharmaceutical Grade Injectable Activated Carbon Market Concentration Rate
2.9.2 Global 5 and 10 Largest Pharmaceutical Grade Injectable Activated Carbon Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Pharmaceutical Grade Injectable Activated Carbon Production by Region
3.1 Global Pharmaceutical Grade Injectable Activated Carbon Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Pharmaceutical Grade Injectable Activated Carbon Production Value by Region (2020-2031)
3.2.1 Global Pharmaceutical Grade Injectable Activated Carbon Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Pharmaceutical Grade Injectable Activated Carbon by Region (2026-2031)
3.3 Global Pharmaceutical Grade Injectable Activated Carbon Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Pharmaceutical Grade Injectable Activated Carbon Production Volume by Region (2020-2031)
3.4.1 Global Pharmaceutical Grade Injectable Activated Carbon Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Pharmaceutical Grade Injectable Activated Carbon by Region (2026-2031)
3.5 Global Pharmaceutical Grade Injectable Activated Carbon Market Price Analysis by Region (2020-2025)
3.6 Global Pharmaceutical Grade Injectable Activated Carbon Production and Value, Year-over-Year Growth
3.6.1 North America Pharmaceutical Grade Injectable Activated Carbon Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Pharmaceutical Grade Injectable Activated Carbon Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Pharmaceutical Grade Injectable Activated Carbon Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Pharmaceutical Grade Injectable Activated Carbon Production Value Estimates and Forecasts (2020-2031)
4 Pharmaceutical Grade Injectable Activated Carbon Consumption by Region
4.1 Global Pharmaceutical Grade Injectable Activated Carbon Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Pharmaceutical Grade Injectable Activated Carbon Consumption by Region (2020-2031)
4.2.1 Global Pharmaceutical Grade Injectable Activated Carbon Consumption by Region (2020-2025)
4.2.2 Global Pharmaceutical Grade Injectable Activated Carbon Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Pharmaceutical Grade Injectable Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Pharmaceutical Grade Injectable Activated Carbon Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Pharmaceutical Grade Injectable Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Pharmaceutical Grade Injectable Activated Carbon Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Pharmaceutical Grade Injectable Activated Carbon Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Pharmaceutical Grade Injectable Activated Carbon Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Pharmaceutical Grade Injectable Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Pharmaceutical Grade Injectable Activated Carbon Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Pharmaceutical Grade Injectable Activated Carbon Production by Type (2020-2031)
5.1.1 Global Pharmaceutical Grade Injectable Activated Carbon Production by Type (2020-2025)
5.1.2 Global Pharmaceutical Grade Injectable Activated Carbon Production by Type (2026-2031)
5.1.3 Global Pharmaceutical Grade Injectable Activated Carbon Production Market Share by Type (2020-2031)
5.2 Global Pharmaceutical Grade Injectable Activated Carbon Production Value by Type (2020-2031)
5.2.1 Global Pharmaceutical Grade Injectable Activated Carbon Production Value by Type (2020-2025)
5.2.2 Global Pharmaceutical Grade Injectable Activated Carbon Production Value by Type (2026-2031)
5.2.3 Global Pharmaceutical Grade Injectable Activated Carbon Production Value Market Share by Type (2020-2031)
5.3 Global Pharmaceutical Grade Injectable Activated Carbon Price by Type (2020-2031)
6 Segment by Application
6.1 Global Pharmaceutical Grade Injectable Activated Carbon Production by Application (2020-2031)
6.1.1 Global Pharmaceutical Grade Injectable Activated Carbon Production by Application (2020-2025)
6.1.2 Global Pharmaceutical Grade Injectable Activated Carbon Production by Application (2026-2031)
6.1.3 Global Pharmaceutical Grade Injectable Activated Carbon Production Market Share by Application (2020-2031)
6.2 Global Pharmaceutical Grade Injectable Activated Carbon Production Value by Application (2020-2031)
6.2.1 Global Pharmaceutical Grade Injectable Activated Carbon Production Value by Application (2020-2025)
6.2.2 Global Pharmaceutical Grade Injectable Activated Carbon Production Value by Application (2026-2031)
6.2.3 Global Pharmaceutical Grade Injectable Activated Carbon Production Value Market Share by Application (2020-2031)
6.3 Global Pharmaceutical Grade Injectable Activated Carbon Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Calgon Carbon
7.1.1 Calgon Carbon Pharmaceutical Grade Injectable Activated Carbon Company Information
7.1.2 Calgon Carbon Pharmaceutical Grade Injectable Activated Carbon Product Portfolio
7.1.3 Calgon Carbon Pharmaceutical Grade Injectable Activated Carbon Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Calgon Carbon Main Business and Markets Served
7.1.5 Calgon Carbon Recent Developments/Updates
7.2 Fujian Yuanli Activated Carbon
7.2.1 Fujian Yuanli Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Company Information
7.2.2 Fujian Yuanli Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Product Portfolio
7.2.3 Fujian Yuanli Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Fujian Yuanli Activated Carbon Main Business and Markets Served
7.2.5 Fujian Yuanli Activated Carbon Recent Developments/Updates
7.3 Zhejiang Xingda Activated Carbon
7.3.1 Zhejiang Xingda Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Company Information
7.3.2 Zhejiang Xingda Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Product Portfolio
7.3.3 Zhejiang Xingda Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Zhejiang Xingda Activated Carbon Main Business and Markets Served
7.3.5 Zhejiang Xingda Activated Carbon Recent Developments/Updates
7.4 Jiangsu Zhuxi Activated Carbon
7.4.1 Jiangsu Zhuxi Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Company Information
7.4.2 Jiangsu Zhuxi Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Product Portfolio
7.4.3 Jiangsu Zhuxi Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Jiangsu Zhuxi Activated Carbon Main Business and Markets Served
7.4.5 Jiangsu Zhuxi Activated Carbon Recent Developments/Updates
7.5 Shanghai Activated Carbon
7.5.1 Shanghai Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Company Information
7.5.2 Shanghai Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Product Portfolio
7.5.3 Shanghai Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Shanghai Activated Carbon Main Business and Markets Served
7.5.5 Shanghai Activated Carbon Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Pharmaceutical Grade Injectable Activated Carbon Industry Chain Analysis
8.2 Pharmaceutical Grade Injectable Activated Carbon Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Pharmaceutical Grade Injectable Activated Carbon Production Mode & Process Analysis
8.4 Pharmaceutical Grade Injectable Activated Carbon Sales and Marketing
8.4.1 Pharmaceutical Grade Injectable Activated Carbon Sales Channels
8.4.2 Pharmaceutical Grade Injectable Activated Carbon Distributors
8.5 Pharmaceutical Grade Injectable Activated Carbon Customer Analysis
9 Pharmaceutical Grade Injectable Activated Carbon Market Dynamics
9.1 Pharmaceutical Grade Injectable Activated Carbon Industry Trends
9.2 Pharmaceutical Grade Injectable Activated Carbon Market Drivers
9.3 Pharmaceutical Grade Injectable Activated Carbon Market Challenges
9.4 Pharmaceutical Grade Injectable Activated Carbon Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Pharmaceutical Grade Injectable Activated Carbon Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Pharmaceutical Grade Injectable Activated Carbon Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Pharmaceutical Grade Injectable Activated Carbon Production Capacity (Tons) by Manufacturers in 2024
Table 4. Global Pharmaceutical Grade Injectable Activated Carbon Production by Manufacturers (2020-2025) & (Tons)
Table 5. Global Pharmaceutical Grade Injectable Activated Carbon Production Market Share by Manufacturers (2020-2025)
Table 6. Global Pharmaceutical Grade Injectable Activated Carbon Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Pharmaceutical Grade Injectable Activated Carbon Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Pharmaceutical Grade Injectable Activated Carbon, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Pharmaceutical Grade Injectable Activated Carbon as of 2024)
Table 10. Global Market Pharmaceutical Grade Injectable Activated Carbon Average Price by Manufacturers (US$/Ton) & (2020-2025)
Table 11. Global Key Manufacturers of Pharmaceutical Grade Injectable Activated Carbon, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Pharmaceutical Grade Injectable Activated Carbon, Product Offered and Application
Table 13. Global Key Manufacturers of Pharmaceutical Grade Injectable Activated Carbon, Date of Enter into This Industry
Table 14. Global Pharmaceutical Grade Injectable Activated Carbon Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical Grade Injectable Activated Carbon Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Pharmaceutical Grade Injectable Activated Carbon Production Value Market Share by Region (2020-2025)
Table 19. Global Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Pharmaceutical Grade Injectable Activated Carbon Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Pharmaceutical Grade Injectable Activated Carbon Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Pharmaceutical Grade Injectable Activated Carbon Production (Tons) by Region (2020-2025)
Table 23. Global Pharmaceutical Grade Injectable Activated Carbon Production Market Share by Region (2020-2025)
Table 24. Global Pharmaceutical Grade Injectable Activated Carbon Production (Tons) Forecast by Region (2026-2031)
Table 25. Global Pharmaceutical Grade Injectable Activated Carbon Production Market Share Forecast by Region (2026-2031)
Table 26. Global Pharmaceutical Grade Injectable Activated Carbon Market Average Price (US$/Ton) by Region (2020-2025)
Table 27. Global Pharmaceutical Grade Injectable Activated Carbon Market Average Price (US$/Ton) by Region (2026-2031)
Table 28. Global Pharmaceutical Grade Injectable Activated Carbon Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 29. Global Pharmaceutical Grade Injectable Activated Carbon Consumption by Region (2020-2025) & (Tons)
Table 30. Global Pharmaceutical Grade Injectable Activated Carbon Consumption Market Share by Region (2020-2025)
Table 31. Global Pharmaceutical Grade Injectable Activated Carbon Forecasted Consumption by Region (2026-2031) & (Tons)
Table 32. Global Pharmaceutical Grade Injectable Activated Carbon Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Pharmaceutical Grade Injectable Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 34. North America Pharmaceutical Grade Injectable Activated Carbon Consumption by Country (2020-2025) & (Tons)
Table 35. North America Pharmaceutical Grade Injectable Activated Carbon Consumption by Country (2026-2031) & (Tons)
Table 36. Europe Pharmaceutical Grade Injectable Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 37. Europe Pharmaceutical Grade Injectable Activated Carbon Consumption by Country (2020-2025) & (Tons)
Table 38. Europe Pharmaceutical Grade Injectable Activated Carbon Consumption by Country (2026-2031) & (Tons)
Table 39. Asia Pacific Pharmaceutical Grade Injectable Activated Carbon Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 40. Asia Pacific Pharmaceutical Grade Injectable Activated Carbon Consumption by Region (2020-2025) & (Tons)
Table 41. Asia Pacific Pharmaceutical Grade Injectable Activated Carbon Consumption by Region (2026-2031) & (Tons)
Table 42. Latin America, Middle East & Africa Pharmaceutical Grade Injectable Activated Carbon Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 43. Latin America, Middle East & Africa Pharmaceutical Grade Injectable Activated Carbon Consumption by Country (2020-2025) & (Tons)
Table 44. Latin America, Middle East & Africa Pharmaceutical Grade Injectable Activated Carbon Consumption by Country (2026-2031) & (Tons)
Table 45. Global Pharmaceutical Grade Injectable Activated Carbon Production (Tons) by Type (2020-2025)
Table 46. Global Pharmaceutical Grade Injectable Activated Carbon Production (Tons) by Type (2026-2031)
Table 47. Global Pharmaceutical Grade Injectable Activated Carbon Production Market Share by Type (2020-2025)
Table 48. Global Pharmaceutical Grade Injectable Activated Carbon Production Market Share by Type (2026-2031)
Table 49. Global Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Pharmaceutical Grade Injectable Activated Carbon Production Value Market Share by Type (2020-2025)
Table 52. Global Pharmaceutical Grade Injectable Activated Carbon Production Value Market Share by Type (2026-2031)
Table 53. Global Pharmaceutical Grade Injectable Activated Carbon Price (US$/Ton) by Type (2020-2025)
Table 54. Global Pharmaceutical Grade Injectable Activated Carbon Price (US$/Ton) by Type (2026-2031)
Table 55. Global Pharmaceutical Grade Injectable Activated Carbon Production (Tons) by Application (2020-2025)
Table 56. Global Pharmaceutical Grade Injectable Activated Carbon Production (Tons) by Application (2026-2031)
Table 57. Global Pharmaceutical Grade Injectable Activated Carbon Production Market Share by Application (2020-2025)
Table 58. Global Pharmaceutical Grade Injectable Activated Carbon Production Market Share by Application (2026-2031)
Table 59. Global Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Pharmaceutical Grade Injectable Activated Carbon Production Value Market Share by Application (2020-2025)
Table 62. Global Pharmaceutical Grade Injectable Activated Carbon Production Value Market Share by Application (2026-2031)
Table 63. Global Pharmaceutical Grade Injectable Activated Carbon Price (US$/Ton) by Application (2020-2025)
Table 64. Global Pharmaceutical Grade Injectable Activated Carbon Price (US$/Ton) by Application (2026-2031)
Table 65. Calgon Carbon Pharmaceutical Grade Injectable Activated Carbon Company Information
Table 66. Calgon Carbon Pharmaceutical Grade Injectable Activated Carbon Specification and Application
Table 67. Calgon Carbon Pharmaceutical Grade Injectable Activated Carbon Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 68. Calgon Carbon Main Business and Markets Served
Table 69. Calgon Carbon Recent Developments/Updates
Table 70. Fujian Yuanli Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Company Information
Table 71. Fujian Yuanli Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Specification and Application
Table 72. Fujian Yuanli Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Fujian Yuanli Activated Carbon Main Business and Markets Served
Table 74. Fujian Yuanli Activated Carbon Recent Developments/Updates
Table 75. Zhejiang Xingda Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Company Information
Table 76. Zhejiang Xingda Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Specification and Application
Table 77. Zhejiang Xingda Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Zhejiang Xingda Activated Carbon Main Business and Markets Served
Table 79. Zhejiang Xingda Activated Carbon Recent Developments/Updates
Table 80. Jiangsu Zhuxi Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Company Information
Table 81. Jiangsu Zhuxi Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Specification and Application
Table 82. Jiangsu Zhuxi Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Jiangsu Zhuxi Activated Carbon Main Business and Markets Served
Table 84. Jiangsu Zhuxi Activated Carbon Recent Developments/Updates
Table 85. Shanghai Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Company Information
Table 86. Shanghai Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Specification and Application
Table 87. Shanghai Activated Carbon Pharmaceutical Grade Injectable Activated Carbon Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Shanghai Activated Carbon Main Business and Markets Served
Table 89. Shanghai Activated Carbon Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Pharmaceutical Grade Injectable Activated Carbon Distributors List
Table 93. Pharmaceutical Grade Injectable Activated Carbon Customers List
Table 94. Pharmaceutical Grade Injectable Activated Carbon Market Trends
Table 95. Pharmaceutical Grade Injectable Activated Carbon Market Drivers
Table 96. Pharmaceutical Grade Injectable Activated Carbon Market Challenges
Table 97. Pharmaceutical Grade Injectable Activated Carbon Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharmaceutical Grade Injectable Activated Carbon
Figure 2. Global Pharmaceutical Grade Injectable Activated Carbon Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Pharmaceutical Grade Injectable Activated Carbon Market Share by Type: 2024 VS 2031
Figure 4. For Injection Type 732 Product Picture
Figure 5. For Injection Type 767 Product Picture
Figure 6. For Injection Type 769 Product Picture
Figure 7. Other Product Picture
Figure 8. Global Pharmaceutical Grade Injectable Activated Carbon Market Value by Application, (US$ Million) & (2020-2031)
Figure 9. Global Pharmaceutical Grade Injectable Activated Carbon Market Share by Application: 2024 VS 2031
Figure 10. Small Volume Injection
Figure 11. Large Volume Injection
Figure 12. Powder for Injection
Figure 13. Other
Figure 14. Global Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million) & (2020-2031)
Figure 16. Global Pharmaceutical Grade Injectable Activated Carbon Production Capacity (Tons) & (2020-2031)
Figure 17. Global Pharmaceutical Grade Injectable Activated Carbon Production (Tons) & (2020-2031)
Figure 18. Global Pharmaceutical Grade Injectable Activated Carbon Average Price (US$/Ton) & (2020-2031)
Figure 19. Pharmaceutical Grade Injectable Activated Carbon Report Years Considered
Figure 20. Pharmaceutical Grade Injectable Activated Carbon Production Share by Manufacturers in 2024
Figure 21. Global Pharmaceutical Grade Injectable Activated Carbon Production Value Share by Manufacturers (2024)
Figure 22. Pharmaceutical Grade Injectable Activated Carbon Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. The Global 5 and 10 Largest Players: Market Share by Pharmaceutical Grade Injectable Activated Carbon Revenue in 2024
Figure 24. Global Pharmaceutical Grade Injectable Activated Carbon Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 25. Global Pharmaceutical Grade Injectable Activated Carbon Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 26. Global Pharmaceutical Grade Injectable Activated Carbon Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 27. Global Pharmaceutical Grade Injectable Activated Carbon Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 28. North America Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. Europe Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million) Growth Rate (2020-2031)
Figure 30. China Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million) Growth Rate (2020-2031)
Figure 31. Japan Pharmaceutical Grade Injectable Activated Carbon Production Value (US$ Million) Growth Rate (2020-2031)
Figure 32. Global Pharmaceutical Grade Injectable Activated Carbon Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 33. Global Pharmaceutical Grade Injectable Activated Carbon Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 34. North America Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 35. North America Pharmaceutical Grade Injectable Activated Carbon Consumption Market Share by Country (2020-2031)
Figure 36. U.S. Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 37. Canada Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 38. Europe Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 39. Europe Pharmaceutical Grade Injectable Activated Carbon Consumption Market Share by Country (2020-2031)
Figure 40. Germany Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 41. France Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 42. U.K. Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 43. Italy Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 44. Russia Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 45. Asia Pacific Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 46. Asia Pacific Pharmaceutical Grade Injectable Activated Carbon Consumption Market Share by Region (2020-2031)
Figure 47. China Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 48. Japan Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 49. South Korea Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 50. China Taiwan Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 51. Southeast Asia Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 52. India Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 53. Latin America, Middle East & Africa Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 54. Latin America, Middle East & Africa Pharmaceutical Grade Injectable Activated Carbon Consumption Market Share by Country (2020-2031)
Figure 55. Mexico Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 56. Brazil Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 57. Turkey Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 58. GCC Countries Pharmaceutical Grade Injectable Activated Carbon Consumption and Growth Rate (2020-2031) & (Tons)
Figure 59. Global Production Market Share of Pharmaceutical Grade Injectable Activated Carbon by Type (2020-2031)
Figure 60. Global Production Value Market Share of Pharmaceutical Grade Injectable Activated Carbon by Type (2020-2031)
Figure 61. Global Pharmaceutical Grade Injectable Activated Carbon Price (US$/Ton) by Type (2020-2031)
Figure 62. Global Production Market Share of Pharmaceutical Grade Injectable Activated Carbon by Application (2020-2031)
Figure 63. Global Production Value Market Share of Pharmaceutical Grade Injectable Activated Carbon by Application (2020-2031)
Figure 64. Global Pharmaceutical Grade Injectable Activated Carbon Price (US$/Ton) by Application (2020-2031)
Figure 65. Pharmaceutical Grade Injectable Activated Carbon Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
